Sir,
The known diabetogenic action of growth hormone and its abnormal regulation in diabetes mellitus [2] [3] [4] suggest a possible role for this hormone in the pathogenesis of diabetic ketoacidosis and chronic diabetic complications [5] . We have investigated the growth hormone response to a rapid lowering of hyperglycaemic plasma glucose levels. In nine diabetic [four Type 1 (insulin-dependent) and five Type 2 (non-insulin-dependent)] and five normal subjects, matched for age and sex, the plasma glucose concentration was raised and maintained at an average of 8.1_+1.6mmol/1 above the basal level of 13.0+ 3.8 mmol/1 for 30 min (25 g glucose as 25% glucose solution IV over 5 rain, followed by a slow IV infusion of 20% glucose solution). At the end of the 30 rain of sustained hyperglycaemia, the glucose infusion was discontinued and an IV bolus of insulin (0.3 U/kg body weight) was administered. The plasma glucose concentration was allowed to No normal subjects released growth hormone during the study. In contrast, six of the nine diabetic patients (three Type I and three Type 2; Figs. 1 and 2) released growth hormone during or shortly after the fall in glucose concentration. These results suggest that rapidly declining hyperglycaemia may stimulate the release of growth hormone in Type 1 and non-obese Type 2 diabetic patients. This response is not seen in normal subjects. The release of growth hormone is likely to be induced by the rapid fall in glucose. Reaching a threshold level of plasma glucose probably acts as a trigger for growth hormone release, reflecting an upward resetting of the glucostat in diabetic subjects [6] , although this cannot be substantiated by these data.
In view of the debated role of growth hormone in the pathogenesis of diabetes mellitus and its chronic complications, the abnormal release of growth hormone during a decrease in plasma glucose level in diabetes may have clinical significance. Intermittent elevations of growth hormone may also contribute to the problems of diabetic control.
Yours sincerely,
E. O. Grecu and R. M. Walter

Short-term Changes in Levels of Circulating T3 and Reverse T3 in Type I (Insulin-Dependent) Diabetic Patients
Dear Sir, Several studies have shown that Type 1 diabetic patients with severe metablic upset have low levels of serum T3 and high levels of reverse T311, 2]. Recently, Schlienger et al. [3] found low T3 and high reverse T3 levels in Type 1 diabetic patients the morning after admission for periodic evaluation and/or adjustment of treatment. They found a correlation between T3 and glycosylated haemoglobin Alc, suggesting that long-term diabetic control may determine the plasma T3 levels. No correlation was shown between glycosylated haemoglobin Ale and reverse T3.
In an earlier study, we emphasised the influence of short-term metablic control on levels of T3 and reverse T3 [4] . We examined the earliest possible phase of development of metabolic control with IV insulin infusion and found a significant decrease in T3 within 1 h of withdrawal of insulin. After 12 h of insulin withdrawal, a mean 29% decrease in T3 level was seen (Table I ). The concentration of reverse Tz was increased significantly after 8 h of insulin withdrawal; an average increase of 37% in reverse T3 was seen after 12 h of insulin withdrawal (Table 1) .
Therefore not only long-term metablic control, but also short-term changes, seem to be of importance in determing the serum levels of T3 and reverse T3 in Type 1 diabetic patients.
No Linkage Between HLA and Maturity Onset Hyperglycaemia in the Young
Yours sincerely, S. Madsbad Dear Sir, Platz et al. [1] have recently failed to find evidence for linkage between HLA and maturity onset hyperglycaemia in the young (MOHY) in a large kindred. They mention our previous report [2] which suggested possible linkage with HLA in a similar family we had studied.
We have recently typed for HLA and analysed for association and linkage in ten large MOHY families. Like Platz et al., we have found no evidence for linkage (unpublished observations). Thus, we agree with them that MOHY is probably neither associated nor linked to HLA. 
